Ahmad Bakar - Millennium Pharmacon Pres Director
| SDPC Stock | IDR 137.00 1.00 0.72% |
Director
Mr. Ahmad bin Abu Bakar serves as Director of PT Millennium Pharmacon International Tbk since May 23, 2012. He is a registered pharmacist in Malaysia. He obtained Bachelor of Pharmacy from Bradford University, UK . He has over 20 years of pharmaceutical experiences and has worked in various fields of pharmacy, including retail and wholesale pharmacy, manufacturing and private hospital. He has worked with Pharmaniaga Logistics Sdn Bhd . He is a member of Company Management Risk Committee. since 2012.
| Age | 54 |
| Tenure | 12 years |
| Phone | 62 21 270 85961 |
| Web | https://www.mpi-indonesia.co.id |
Millennium Pharmacon Management Efficiency
The company has return on total asset (ROA) of 0.0342 % which means that it generated a profit of $0.0342 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0938 %, meaning that it generated $0.0938 on every $100 dollars invested by stockholders. Millennium Pharmacon's management efficiency ratios could be used to measure how well Millennium Pharmacon manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | DIRECTOR Age | ||
| Eka Djaja | Wicaksana Overseas Internationa | 56 | |
| Artha Aprillailie | Wahana Pronatural | 46 | |
| Lenny Trianjayani | Hotel Sahid Jaya | 54 | |
| Sebastian Kinaatmaja | Tempo Inti Media | N/A | |
| Meiky Sofiansyah | Tempo Inti Media | 54 | |
| Arif Zulkifli | Tempo Inti Media | 53 | |
| Herry Hernawan | Tempo Inti Media | 59 | |
Management Performance
| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 |
Millennium Pharmacon Leadership Team
Elected by the shareholders, the Millennium Pharmacon's board of directors comprises two types of representatives: Millennium Pharmacon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Millennium. The board's role is to monitor Millennium Pharmacon's management team and ensure that shareholders' interests are well served. Millennium Pharmacon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Millennium Pharmacon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ahmad Bakar, Pres Director | ||
| Morsela, Ma Marketing | ||
| Mohamad Hassan, F Director | ||
| Aris, Chairman Audit | ||
| Puji Hartono, Head Unit | ||
| Dedi Martadiredja, Sr Sales | ||
| Yungkis Sucandra, Head Unit | ||
| Olga Bolang, Co Sec | ||
| Yuni Arrivani, Deputy Legal |
Millennium Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Millennium Pharmacon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 828.27 B | |||
| Shares Outstanding | 1.27 B | |||
| Shares Owned By Insiders | 87.94 % | |||
| Shares Owned By Institutions | 3.35 % | |||
| Price To Earning | 9.31 X | |||
| Price To Book | 1.16 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Millennium Stock
Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.